Birchview Capital, LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Birchview Capital, LP disclosed 61 US equity positions worth $115.5m in its Q3 2024 13F filing. The largest position was BMY at 30.7% of the reported book, followed by BDSX and ACAD.
What did Birchview Capital, LP own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 30.7% | $35.5m | 686,182 | – | |
| 2 | BDSX BIODESIX INC | 8.8% | $10.1m | 5,696,113 | – | ||
| 3 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 5.3% | $6.2m | 400,400 | – | |
| 4 | ELUT ELUTIA INC | 4.4% | $5.0m | 1,321,215 | – | ||
| 5 | UTHR UNITED THERAPEUTICS CORP | Healthcare | 3.1% | $3.6m | 10,000 | – | |
| 6 | PROTHENA CORP PLC | 3.0% | $3.5m | 209,574 | – | ||
| 7 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 3.0% | $3.5m | 30,240 | – | |
| 8 | CORT CORCEPT THERAPEUTICS INC | Healthcare | 3.0% | $3.4m | 74,000 | – | |
| 9 | HROW HARROW HEALTH INC | 2.8% | $3.3m | 72,910 | – | ||
| 10 | QDELUSD QUIDELORTHO CORP | 2.7% | $3.1m | 67,619 | – | ||
| 11 | FHTX FOGHORN THERAPEUTICS INC | Healthcare | 2.6% | $3.0m | 320,930 | – | |
| 12 | AXGN AXOGEN INC | Healthcare | 2.4% | $2.8m | 197,000 | – | |
| 13 | PHR PHREESIA INC | Healthcare | 2.3% | $2.6m | 114,700 | – | |
| 14 | STOK STOKE THERAPEUTICS INC | Healthcare | 2.2% | $2.6m | 210,000 | – | |
| 15 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 1.9% | $2.2m | 48,000 | – | |
| 16 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 1.8% | $2.1m | 148,000 | – | |
| 17 | MASI* MASIMO CORP | 1.8% | $2.0m | 15,280 | – | ||
| 18 | OVV OVINTIV INC | Energy | 1.7% | $2.0m | 52,200 | – | |
| 19 | DCGO DOCGO INC | 1.5% | $1.7m | 515,000 | – | ||
| 20 | CSTL CASTLE BIOSCIENCES INC | Healthcare | 1.4% | $1.7m | 58,000 | – | |
| 21 | ALKS ALKERMES PLC | Healthcare | 1.2% | $1.4m | 50,000 | – | |
| 22 | EQT EQT CORPORATION | Energy | 1.1% | $1.3m | 34,619 | – | |
| 23 | ATEC ALPHATEC HOLDINGS INC | Healthcare | 1.0% | $1.1m | 198,000 | – | |
| 24 | 4XC1 KALVISTA PHARMACEUTICALS INC | 0.8% | $949.6k | 82,000 | – | ||
| 25 | KINIKSA PHARMACEUTICALS LTD | 0.6% | $749.7k | 30,000 | – | ||
| 26 | TXG 10X GENOMICS INC | Healthcare | 0.6% | $677.4k | 30,000 | – | |
| 27 | HALO HALOZYME THERAPEUTICS INC | Healthcare | 0.5% | $572.4k | 10,000 | – | |
| 28 | ACCELERATE DIAGNOSTICS INC | 0.5% | $556.2k | 325,239 | – | ||
| 29 | CYTK CYTOKINETICS INC | Healthcare | 0.5% | $528.0k | 10,000 | – | |
| 30 | INBX INHIBRX BIOSCIENCES INC | 0.4% | $502.8k | 32,110 | – | ||
| 31 | KROS KEROS THERAPEUTICS INC | Healthcare | 0.4% | $406.5k | 7,000 | – | |
| 32 | APLSUSD APELLIS PHARMACEUTICALS INC | 0.3% | $403.8k | 14,000 | – | ||
| 33 | TMCI TREACE MEDICAL CONCEPTS INC | Healthcare | 0.3% | $396.4k | 68,350 | – | |
| 34 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.3% | $393.7k | 10,000 | – | |
| 35 | KPTI KARYOPHARM THERAPEUTICS INC | Healthcare | 0.3% | $390.0k | 469,832 | – | |
| 36 | CHRS COHERUS BIOSCIENCES INC | Healthcare | 0.3% | $386.9k | 372,000 | – | |
| 37 | ARVN ARVINAS INC | Healthcare | 0.3% | $369.4k | 15,000 | – | |
| 38 | PGNY PROGYNY INC | Healthcare | 0.3% | $368.7k | 22,000 | – | |
| 39 | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | 0.3% | $368.0k | 7,365 | – | ||
| 40 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 0.3% | $359.5k | 4,000 | – | |
| 41 | CGEM CULLINAN ONCOLOGY INC | Healthcare | 0.3% | $334.8k | 20,000 | – | |
| 42 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 0.3% | $328.0k | 40,000 | – | |
| 43 | SWTXUSD SPRINGWORKS THERAPEUTICS INC | 0.3% | $320.4k | 10,000 | – | ||
| 44 | NVCR NOVOCURE LTD | Healthcare | 0.3% | $312.6k | 20,000 | – | |
| 45 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 0.3% | $312.2k | 2,500 | – | |
| 46 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 0.3% | $304.0k | 40,000 | – | |
| 47 | AM6 AMICUS THERAPEUTICS INC | 0.3% | $299.0k | 28,000 | – | ||
| 48 | 2655787D BLUEPRINT MEDICINES CORP | 0.2% | $249.8k | 2,700 | – | ||
| 49 | XNCR XENCOR INC | Healthcare | 0.2% | $247.4k | 12,300 | – | |
| 50 | GOSS GOSSAMER BIO INC | Healthcare | 0.1% | $136.3k | 138,176 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.